Some further characteristics of endogenous proteinase inhibitors.
Leucocytes and spleen contain four different types of protein proteinase inhibitors. Two of them can be inactivated by cathepsin D. In this work biochemical and immunological studies of the inactivation of I-2 by cathepsin D are presented. Polyacrylamide gel electrophoretic examinations indicate that cathepsin D inactivates I-2 by hydrolysis of the inhibitor molecule. The conversion of the active inhibitor into inactive protein proceeds catalytically. The studies on the inhibitor mechanism of the isoinhibitors of I-1 type explain the unusual inhibitor property of this type of inhibitor to inhibit two different types of proteinases, cysteine and serine. The evidence suggests that the inhibitory mechanism is based on an active sulfhydryl group of the inhibitor which may interact with the disulfide bridge of the inhibited proteinase.
D000818:Animals; D002401:Cathepsin B; D002402:Cathepsin D; D002403:Cathepsins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D003546:Cysteine Endopeptidases; D006863:Hydrogen-Ion Concentration; D007962:Leukocytes / Q000201:enzymology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000473:pathology; D010206:Papain / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D012697:Serine Endopeptidases; D013154:Spleen / Q000201:enzymology*; D013552:Swine
D011480:Protease Inhibitors; D002403:Cathepsins; D012697:Serine Endopeptidases; D003546:Cysteine Endopeptidases; D002401:Cathepsin B; D010206:Papain; D002402:Cathepsin D; D003545:Cysteine